Madison Asset Management, LLC Genmab A/S Transaction History

Madison Asset Management, LLC

$8.04 Billion
Q3 2024

A detailed history of Madison Asset Management, LLC transactions in Genmab A/S stock. As of the latest transaction made, Madison Asset Management, LLC holds 67,689 shares of GMAB stock, worth $1.39 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

67,689

Previous 58,575 15.56%

Holding current value

$1.39 Million

Previous $1.47 Million 12.17%

% of portfolio

0.02%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$23.84 - $28.48 $217,277 - $259,566	9,114 Added 15.56%	67,689 $1.65 Million
Q2 2024 Aug 09, 2024	SELL	$25.13 - $30.27 $77,877 - $93,806	-3,099 Reduced 5.02%	58,575 $1.47 Million
Q1 2024 May 09, 2024	BUY	$26.43 - $32.77 $336,506 - $417,227	12,732 Added 26.01%	61,674 $1.84 Million
Q4 2023 Feb 12, 2024	SELL	$27.94 - $35.44 $740,214 - $938,911	-26,493 Reduced 35.12%	48,942 $1.56 Million
Q3 2023 Nov 13, 2023	BUY	$35.27 - $42.24 $308,189 - $369,093	8,738 Added 13.1%	75,435 $2.66 Million
Q2 2023 Aug 01, 2023	SELL	$37.4 - $42.94 $22,701 - $26,064	-607 Reduced 0.9%	66,697 $2.54 Million
Q1 2023 Apr 26, 2023	BUY	$34.88 - $43.22 $296,305 - $367,153	8,495 Added 14.45%	67,304 $2.54 Million
Q4 2022 Feb 08, 2023	SELL	$33.8 - $47.06 $426,893 - $594,367	-12,630 Reduced 17.68%	58,809 $2.49 Million
Q3 2022 Nov 10, 2022	BUY	$31.52 - $373.61 $465,771 - $5.52 Million	14,777 Added 26.08%	71,439 $2.3 Million
Q2 2022 Aug 09, 2022	SELL	$26.83 - $38.57 $117,676 - $169,168	-4,386 Reduced 7.18%	56,662 $1.84 Million
Q1 2022 May 12, 2022	BUY	$30.95 - $39.68 $342,492 - $439,098	11,066 Added 22.14%	61,048 $2.21 Million
Q4 2021 Feb 15, 2022	SELL	$35.87 - $47.12 $574,422 - $754,579	-16,014 Reduced 24.27%	49,982 $1.98 Million
Q3 2021 Nov 12, 2021	BUY	$41.55 - $48.72 $455,097 - $533,630	10,953 Added 19.9%	65,996 $2.88 Million
Q2 2021 Aug 09, 2021	SELL	$32.88 - $44.57 $326,794 - $442,981	-9,939 Reduced 15.3%	55,043 $2.25 Million
Q1 2021 May 11, 2021	SELL	$30.92 - $44.4 $149,065 - $214,052	-4,821 Reduced 6.91%	64,982 $2.13 Million
Q4 2020 Feb 12, 2021	BUY	$33.66 - $40.76 $2.35 Million - $2.85 Million	69,803 New	69,803 $2.84 Million

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Madison Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Madison Asset Management, LLC with notifications on news.

Account

Madison Asset Management, LLC Genmab A/S Transaction History